CareBand Tracking Bracelet Wins NIH Award, May Detect Agitation in Alzheimer’s, Related Dementias

CareBand Tracking Bracelet Wins NIH Award, May Detect Agitation in Alzheimer’s, Related Dementias
CareBand’s tracking bracelet, which pairs GPS technology to track movement and activity in real time, has been granted the National Institutes of Health (NIH) Phase 1 Small Business Innovation Research (SBIR) Award to test whether it may help detect and predict agitation in patients with Alzheimer's disease and related dementias. Agitation is reported in almost 50% of Alzheimer’s patients, and is often an umbrella term to refer to restlessness, emotional distress, aggressive behaviors, disruptive irritability, and loss of social awareness. People with agitation are more likely to be given high-risk psychotropic medications and have a higher chance of harming themselves or others, which may result in removal from home or care facilities. A device that can measure agitation could potentially help to reduce stress triggers, enhance care, and decrease costs and caregiver burden. The CareBand tracking bracelet monitors an individual’s precise location, both indoors and outdoors, as well as movement and activity in real time. It uses low-power technology, meaning it has a long battery life. The SBIR Program is structured in three phases. In Phase 1, the CareBand system will be used to collect data over six weeks in people with Alzheimer's and related dementias living at Bethany Village, a long-term care facility in Indianapolis. Durin
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *